|
Fusion gene ID: 12333 |
FusionGeneSummary for EXT2_ALKBH3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: EXT2_ALKBH3 | Fusion gene ID: 12333 | Hgene | Tgene | Gene symbol | EXT2 | ALKBH3 | Gene ID | 2132 | 221120 |
Gene name | exostosin glycosyltransferase 2 | alkB homolog 3, alpha-ketoglutaratedependent dioxygenase | |
Synonyms | SOTV|SSMS | ABH3|DEPC-1|DEPC1|PCA1|hABH3 | |
Cytomap | 11p11.2 | 11p11.2 | |
Type of gene | protein-coding | protein-coding | |
Description | exostosin-2N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferaseglucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferasemultiple exostoses protein 2multiple exostosis 2putativ | alpha-ketoglutarate-dependent dioxygenase alkB homolog 3alkB homolog 3, alpha-ketoglutarate-dependent dioxygenasealkB, alkylation repair homolog 3alkylated DNA repair protein alkB homolog 3prostate cancer antigen-1 | |
Modification date | 20180522 | 20180519 | |
UniProtAcc | Q93063 | Q96Q83 | |
Ensembl transtripts involved in fusion gene | ENST00000533608, ENST00000358681, ENST00000395673, ENST00000343631, ENST00000529186, | ENST00000302708, ENST00000378840, ENST00000532410, | |
Fusion gene scores | * DoF score | 4 X 4 X 5=80 | 4 X 3 X 5=60 |
# samples | 5 | 5 | |
** MAII score | log2(5/80*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/60*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: EXT2 [Title/Abstract] AND ALKBH3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, retained protein feature but frameshift. DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain. DDR (DNA damage repair) gene involved fusion gene, retained protein feature but frameshift. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | EXT2 | GO:0006024 | glycosaminoglycan biosynthetic process | 12907669 |
Hgene | EXT2 | GO:0033692 | cellular polysaccharide biosynthetic process | 12907669 |
Tgene | ALKBH3 | GO:0006281 | DNA repair | 16858410 |
Tgene | ALKBH3 | GO:0006307 | DNA dealkylation involved in DNA repair | 16858410|22055184 |
Tgene | ALKBH3 | GO:0035552 | oxidative single-stranded DNA demethylation | 16858410 |
Tgene | ALKBH3 | GO:0035553 | oxidative single-stranded RNA demethylation | 26863196|26863410 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | PCPG | TCGA-QR-A6GW-01A | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
TCGA | RV | SKCM | TCGA-ER-A194-01A | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000533608 | ENST00000302708 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-intron | ENST00000533608 | ENST00000378840 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-3UTR | ENST00000533608 | ENST00000532410 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
Frame-shift | ENST00000358681 | ENST00000302708 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-intron | ENST00000358681 | ENST00000378840 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-3UTR | ENST00000358681 | ENST00000532410 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
Frame-shift | ENST00000395673 | ENST00000302708 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-intron | ENST00000395673 | ENST00000378840 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-3UTR | ENST00000395673 | ENST00000532410 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
Frame-shift | ENST00000343631 | ENST00000302708 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-intron | ENST00000343631 | ENST00000378840 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-3UTR | ENST00000343631 | ENST00000532410 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
intron-3CDS | ENST00000529186 | ENST00000302708 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
intron-intron | ENST00000529186 | ENST00000378840 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
intron-3UTR | ENST00000529186 | ENST00000532410 | EXT2 | chr11 | 44219568 | + | ALKBH3 | chr11 | 43940588 | + |
Frame-shift | ENST00000533608 | ENST00000302708 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-intron | ENST00000533608 | ENST00000378840 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-3UTR | ENST00000533608 | ENST00000532410 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
Frame-shift | ENST00000358681 | ENST00000302708 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-intron | ENST00000358681 | ENST00000378840 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-3UTR | ENST00000358681 | ENST00000532410 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
Frame-shift | ENST00000395673 | ENST00000302708 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-intron | ENST00000395673 | ENST00000378840 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-3UTR | ENST00000395673 | ENST00000532410 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
Frame-shift | ENST00000343631 | ENST00000302708 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-intron | ENST00000343631 | ENST00000378840 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
5CDS-3UTR | ENST00000343631 | ENST00000532410 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
3UTR-3CDS | ENST00000529186 | ENST00000302708 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
3UTR-intron | ENST00000529186 | ENST00000378840 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
3UTR-3UTR | ENST00000529186 | ENST00000532410 | EXT2 | chr11 | 44135851 | + | ALKBH3 | chr11 | 43940588 | + |
Top |
FusionProtFeatures for EXT2_ALKBH3 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
EXT2 | ALKBH3 |
Glycosyltransferase required for the biosynthesis ofheparan-sulfate. The EXT1/EXT2 complex possesses substantiallyhigher glycosyltransferase activity than EXT1 or EXT2 alone.Appears to be a tumor suppressor. Required for the exosomalrelease of SDCBP, CD63 and syndecan (PubMed:22660413).{ECO:0000269|PubMed:22660413}. | Dioxygenase that mediates demethylation of DNA and RNAcontaining 1-methyladenosine (m1A) (PubMed:12486230,PubMed:12594517, PubMed:16174769, PubMed:26863196,PubMed:26863410). Repairs alkylated DNA containing 1-methyladenosine (m1A) and 3-methylcytosine (m3C) by oxidativedemethylation (PubMed:12486230, PubMed:12594517, PubMed:16174769,PubMed:25944111). Has a strong preference for single-stranded DNA(PubMed:12486230, PubMed:12594517, PubMed:16174769). Able toprocess alkylated m3C within double-stranded regions via itsinteraction with ASCC3, which promotes DNA unwinding to generatesingle-stranded substrate needed for ALKBH3 (PubMed:22055184).Also acts on RNA (PubMed:12594517, PubMed:16174769,PubMed:26863196, PubMed:26863410, PubMed:16858410). DemethylatesN(1)-methyladenosine (m1A) RNA, an epigenetic internalmodification of messenger RNAs (mRNAs) highly enriched within 5'-untranslated regions (UTRs) and in the vicinity of start codons(PubMed:26863196, PubMed:26863410). Requires molecular oxygen,alpha-ketoglutarate and iron (PubMed:22055184, PubMed:16858410).{ECO:0000269|PubMed:12486230, ECO:0000269|PubMed:12594517,ECO:0000269|PubMed:16174769, ECO:0000269|PubMed:16858410,ECO:0000269|PubMed:22055184, ECO:0000269|PubMed:25944111,ECO:0000269|PubMed:26863196, ECO:0000269|PubMed:26863410}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for EXT2_ALKBH3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for EXT2_ALKBH3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
EXT2 | STK16, SNCG, HYOU1, CNTF, TCEB1, RPS29, CRB1, CLEC2L, FABP4, HNF4A, EXT1, EXT2, GALNT5, TRAP1, TK1, CDKN1A, SMN1, ANXA7, PFDN1, GSKIP, SLC22A2, IDS, INVS, TTC19, RBFA, AFAP1, ATE1, CUX1, USP30, NOP9, HLA-DPB1 | ALKBH3 | SRPK2, SRPK1, GOLGA2, IKZF1, GLRX3, LNX1, AK8, ZDHHC17, ASCC3, SMEK1, ASCC2, TRIP4, INPPL1, ASCC1, NEU2, KRAS, HSPA5, MAP1B, TUBB2A, TUBA1A, HSPA8, THRAP3, PRMT5, FLNA, RIF1, MGA, TUBB, TCP1, CCT2, CCT4, DHX15, LTBP1, CCT6A, OTUD4, HSPA2, TUBB3, CCT8, BCLAF1, CLNS1A, HNRNPH1, MATR3, SF3B2, TAB1, EEF1A1, CCT5, TUBB4A, HSPA9, USP7, USP9X |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for EXT2_ALKBH3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | ALKBH3 | Q96Q83 | DB00126 | Vitamin C | Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 {ECO:0000305} | small molecule | approved|nutraceutical |
Top |
RelatedDiseases for EXT2_ALKBH3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | EXT2 | C1851413 | EXOSTOSES, MULTIPLE, TYPE II | 9 | CTD_human;UNIPROT |
Hgene | EXT2 | C0015306 | Hereditary Multiple Exostoses | 1 | CTD_human;HPO;ORPHANET |
Hgene | EXT2 | C4225248 | SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME | 1 | ORPHANET;UNIPROT |